Doctor profile · Federal record
Dr. ROBERT AJELLO, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Internal Medicine Physician · Critical Care Medicine (Internal Medicine) Physician · Sleep Medicine (Internal Medicine) Physician · GREENFIELD, MA
- NPI 1518930916
- Accepts Medicare
- 47 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
164 HIGH ST, SUITE 200
GREENFIELD, MA 013012613
(413) 773-2840
fax (413) 773-2841 - Mailing address
-
280 CHESTNUT ST, 2ND FLOOR
SPRINGFIELD, MA 011991001
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- December 22, 2017
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Massachusetts #76900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518930916. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
563
Distinct HCPCS
6
Medicare allowed
$84,331
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 313 | 262 | $130 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 92 | 92 | $224 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 90 | 82 | $181 | |
95806 |
Sleep study including heart rate, breathing, airflow, and effort | 31 | 30 | $91 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 25 | 24 | $92 | |
99443 |
Telephone medical discussion with physician, 21-30 minutes | 12 | 11 | $130 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 86. This provider delivers 6.5× the peer median.Open Payments
Industry payments received
All-time total
$1,049
Transactions
44
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $138.02 | |
| AstraZeneca Pharmaceuticals LP | 6 | $109.04 | |
| Amgen Inc. | 6 | $97.65 | |
| Merck Sharp & Dohme LLC | 4 | $80.66 | |
| Janssen Pharmaceuticals, Inc | 3 | $78.69 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $75.29 | |
| Alnylam Pharmaceuticals Inc. | 3 | $70.24 | |
| CARDIVA MEDICAL, INC. | 2 | $58.12 | |
| Axsome Therapeutics, Inc. | 2 | $55.25 | |
| United Therapeutics Corporation | 2 | $37.89 | |
| MEDICOMP INC | 1 | $36.90 | |
| HEARTFLOW, INC. | 1 | $35.79 | |
| Harmony Biosciences Llc | 1 | $29.07 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $22.77 | |
| SCPHARMACEUTICALS INC. | 1 | $22.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
275
Patients
75
Total drug cost
$145,912
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 60 | 26 | $79,732 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 49 | 24 | $1,622 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 35 | 14 | $3,198 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 24 | 0 | $17,272 |
| Zafirlukast | Generic | 21 | 11 | $3,540 |
| Azithromycin | Generic | 18 | 0 | $861 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 17 | 0 | $16,016 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 16 | 0 | $12,397 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 12 | 0 | $9,675 |
| Wixela Inhub (Fluticasone Propion/Salmeterol) | Brand | 12 | 0 | $1,095 |